CHRS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $1.16

Capitalizzazione di Mercato (MRQ) $179M

P/E (TTM) -1.1

EPS (TTM) $-1.06

Ricavi (TTM) $51M

ROE (TTM) -146.3%

Intervallo 52 sett. $1–$3

CHRS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Coherus Oncology, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaBiotechnology dipendenti144 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$42M

2016-12-31 → 2025-12-31

EPS$1.43

2017-12-31 → 2025-12-31

Flusso di cassa libero·

2016-12-31 → 2023-12-31

Margine netto-259.4%

2016-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	CHRS	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-1.1media 5 anni ≈-0.2	≈-0.2	·	·
P/S (TTM)	3.5media 5 anni ≈3.7	≈3.7	4.9	Sottovalutato
P/B (MRQ)	2.9media 5 anni ≈1.5	≈1.5	2.8	Più costoso
Price / Cash Flow (Prezzo / Flusso di cassa)	-1.3media 5 anni ≈-9.3	≈-9.3	·	·
Prezzo / Valore contabile tangibile (MRQ)	4.3	·	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	CHRS	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-311.6%media 5 anni ≈-150.6%	≈-150.6%	-609.2%	Di prim'ordine
EBITDA Margin (Margine EBITDA)	-426.4%media 5 anni ≈-149.6%	≈-149.6%	-576.6%	Di prim'ordine
Margine ante imposte (TTM)	-316.4%media 5 anni ≈-148.5%	≈-148.5%	-233.1%	In linea
Margine di Profitto Netto (TTM)	-259.4%media 5 anni ≈18.1%	≈18.1%	-288.3%	Di prim'ordine
ROA (TTM)	-41.9%media 5 anni ≈-15.6%	≈-15.6%	-28.9%	Di prim'ordine
ROE (TTM)	-146.3%media 5 anni ≈60.6%	≈60.6%	-55.7%	Di prim'ordine
ROIC	-296.9%media 5 anni ≈-68.8%	≈-68.8%	-83.9%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	CHRS	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)	1.8media 5 anni ≈2.1	≈2.1	7.9	Bassa liquidità
Quick Ratio (MRQ)	1.6media 5 anni ≈1.8	≈1.8	6.1	Bassa liquidità
Interest Coverage (Copertura degli interessi)	-20.1media 5 anni ≈-9.7	≈-9.7	-42.5	Liquidità elevata

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	CHRS	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	59.8%media 5 anni ≈-15.0%	≈-15.0%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	-41.5%media 5 anni ≈-38.9%	≈-38.9%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	-38.4%	·	·	·
EPS YoY	472.0%	·	·	·
Net Income YoY (Utile Netto YoY)	489.4%	·	·	·
EPS CAGR 5Y (CAGR EPS 5 anni)	-2.5%	·	·	·
Net Income CAGR 5Y (CAGR Utile Netto 5 anni)	4.9%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	CHRS	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$1.43media 5 anni ≈$-1.68	≈$-1.68	·	·
Revenue / Share (Ricavi / Azione)	$0.36media 5 anni ≈$2.49	≈$2.49	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-1.18media 5 anni ≈$-1.36	≈$-1.36	·	·
Cash / Share (Liquidità / Azione)	$0.73media 5 anni ≈$1.79	≈$1.79	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	CHRS	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.1media 5 anni ≈0.4	≈0.4	0.1	In linea
Inventory Turnover (Rotazione delle scorte)	3.7media 5 anni ≈2.4	≈2.4	·	·
Receivables Turnover (Rotazione dei crediti)	0.7media 5 anni ≈1.5	≈1.5	3.4	Debole
Revenue / Employee (Ricavi / Dipendente)	≈$292.9K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media -1.7%

Prossimo report Nov 04, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 5, 2026	$-0.13	$-0.20	36.3%
31 Marzo 2026	Mag 11, 2026	$-0.25	$-0.28	10.3%
31 Dicembre 2025		$-0.34	$-0.35	2.9%
30 Settembre 2025		$-0.33	$-0.33	0.45%
30 Giugno 2025		$-0.34	$-0.30	-12.4%
31 Marzo 2025		$-0.35	$-0.24	-47.9%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 17

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$42M	$26M	$257M	$211M	$327M	$476M	$356M	$0	$2M	$190M	$30M	$31M
Cost of Revenue	$14M	$9M	$159M	$70M	$58M	$38M	$17M	·	·	·	·	·
R&D Expense	$109M	$92M	$109M	$199M	$363M	$143M	$94M	$110M	$162M	$254M	$213M	$78M
SG&A Expense	$101M	$125M	$192M	$198M	$170M	$139M	$137M	$94M	$71M	$52M	$36M	$18M
Operating Expenses	$223M	$226M	$460M	$468M	$590M	$320M	$248M	$204M	$234M	$306M	$249M	$96M
Operating Income	$-181M	$-200M	$-203M	$-257M	$-264M	$156M	$108M	$-204M	$-232M	$-116M	$-219M	$-65M
Interest Expense	$9M	$11M	$41M	$32M	$23M	$21M	$18M	$10M	$10M	$8M	$33.0K	$4M
Interest Income	$7M	$4M	$3M	$2M	$1M	$600.0K	$2M	$1M	·	·	·	·
Other Non-op	$7M	$8M	$5M	$4M	$-283.0K	$554.0K	$3M	$5M	$3M	$-4M	$-5M	$-19M
Pretax Income	$-183M	$-215M	$-238M	$-292M	$-287M	$136M	$93M	$-209M	$-238M	·	·	·
Income Tax	$0	$0	$-380.0K	$0	$0	$3M	$3M	$0	$0	$0	$0	$0
Net Income	$168M	$29M	$-238M	$-292M	$-287M	$132M	$90M	$-209M	$-238M	$-127M	$-223M	$-87M
EPS (Basic)	$1.43	$0.25	$-2.53	$-3.76	$-3.81	$1.85	$1.29	$-3.22	$-4.48	·	·	·
EPS (Diluted)	$1.43	$0.25	$-2.53	$-3.76	$-3.81	$1.62	$1.23	$-3.22	$-4.48	·	·	·
Shares (Basic)	117,143,457	114,553,537	94,162,637	77,630,020	75,449,632	71,411,705	69,679,916	65,034,827	53,133,620	·	37,125,617	8,520,100
Shares (Diluted)	117,143,457	114,553,537	94,162,637	77,630,020	75,449,632	83,491,898	73,185,943	65,034,827	53,133,620	·	·	·
EBITDA	$-180M	$-110M	$-200M	$-257M	$-264M	$156M	$108M	$-204M	$-232M	$-116M	$-219M	$-64M

Stato Patrimoniale 29

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$89M	$126M	$103M	$64M	$417M	$541M	$178M	$72M	$127M	$125M	$158M	$150M
Short-term Investments	$83M	·	$15M	$128M	·	·	$0	$0	·	·	·	·
Receivables	$18M	$111M	$261M	$110M	$123M	$157M	$142M	$0	·	$2M	$2M	$2M
Inventory	$3M	$4M	$63M	$39M	$38M	$44M	$10M	$2M	·	·	·	·
Prepaid Expense	$6M	$10M	$11M	$23M	$11M	$6M	$5M	$2M	$18M	$32M	$35M	$20M
Other Current Assets	·	·	·	·	·	·	·	$83.0K	$142.0K	$3M	$3M	$2M
Current Assets	$207M	$342M	$476M	$381M	$602M	$767M	$343M	$84M	$145M	$161M	$197M	$179M
PP&E (Net)	$1M	$3M	$5M	$9M	$8M	$10M	$6M	$7M	$13M	$11M	$11M	$4M
PP&E (Gross)	·	·	·	·	·	·	$22M	$20M	$23M	$17M	$14M	$6M
Accum. Depreciation	·	·	·	$4M	$4M	$3M	$16M	$13M	$10M	$6M	$4M	$1M
Goodwill	·	·	$943.0K	$943.0K	$900.0K	$943.0K	$943.0K	$943.0K	$943.0K	$943.0K	$943.0K	$943.0K
Intangibles	$20M	$25M	$42M	$6M	$4M	$3M	$3M	$3M	$3M	$3M	$3M	$3M
Other Non-current Assets	$4M	$6M	$10M	$9M	$10M	$13M	$362.0K	$14.0K	$13.0K	$2M	$146.0K	$50.0K
Total Assets	$258M	$449M	$630M	$481M	$679M	$842M	$409M	$99M	$163M	$178M	$212M	$187M
Accounts Payable	$10M	$28M	$35M	$12M	$16M	$15M	$26M	$15M	$15M	$20M	$26M	$9M
Accrued Liabilities	$20M	$60M	$105M	$50M	$48M	$27M	$17M	$7M	$7M	$28M	$24M	$11M
Current Liabilities	$140M	$283M	$332M	$139M	$165M	$146M	$115M	$33M	$28M	$56M	$106M	$52M
Capital Leases	$1M	$3M	$5M	$4M	$7M	$9M	$10M	$0	·	·	·	·
Deferred Tax	$1M	$1M	$1M	·	·	·	·	·	·	·	·	·
Other Non-current Liabilities	$20M	$29M	$13M	$3M	$750.0K	$1M	$0	$2M	$2M	$2M	$2M	$347.0K
Total Liabilities	$197M	$581M	$823M	$618M	$582M	$561M	$304M	$138M	$132M	$159M	$219M	$120M
Long-term Debt	·	·	·	·	·	·	$74M	$0	·	·	·	·
Common Stock	$12.0K	$12.0K	$11.0K	$8.0K	$7.0K	$7.0K	$7.0K	$7.0K	$6.0K	$5.0K	$4.0K	$3.0K
Paid-in Capital	$1.44B	$1.42B	$1.39B	$1.20B	$1.15B	$1.04B	$1.00B	·	·	·	·	·
Retained Earnings	$-1.38B	$-1.55B	$-1.58B	$-1.34B	$-1.05B	$-763M	$-895M	$-985M	$-775M	$-537M	$-410M	$-187M
AOCI	$-195.0K	$-275.0K	$-248.0K	$-249.0K	$-270.0K	$-270.0K	$-558.0K	$-282.0K	$-750.0K	$-630.0K	$-401.0K	$-525.0K
Stockholders' Equity	$61M	$-132M	$-193M	$-137M	$98M	$281M	$105M	$-39M	$31M	$19M	$-6M	$67M
Liabilities + Equity	$258M	$449M	$630M	$481M	$679M	$842M	$409M	$99M	$163M	$178M	$212M	$187M
Shares Outstanding	121,154,925	115,614,548	112,215,260	78,851,516	76,930,096	72,513,348	70,366,661	68,302,681	59,840,467	45,808,163	39,005,589	33,257,978

Flusso di cassa 17

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$1M	$2M	$3M	$4M	$4M	$3M	$3M	$3M	$3M	$3M	$2M	$674.0K
Stock-based Comp	$17M	$28M	$43M	$51M	$51M	$38M	$34M	$35M	$33M	$27M	$17M	$11M
Deferred Tax	·	·	$-380.0K	·	·	·	$0	$0	$0	·	·	·
Amort. of Intangibles	$3M	$3M	·	·	·	·	·	·	·	·	·	·
Restructuring	·	·	·	·	·	·	·	·	$4M	·	·	·
Other Non-cash	$-325M	$-79M	$17M	·	·	·	·	·	·	·	·	$51M
Operating Cash Flow	$-139M	$-20M	$-175M	$-241M	$-37M	$154M	$28M	$-159M	$-200M	$-253M	$-108M	$-24M
CapEx	·	·	$286.0K	$2M	$1M	$7M	$2M	$789.0K	$5M	$7M	$6M	$3M
Investing Cash Flow	$375M	$230M	$145M	$-167M	$-138M	$-14M	$-13M	$-1M	$-4M	$-7M	·	·
Stock Issued	·	$1M	·	·	$41M	·	·	·	·	·	·	·
Stock Repurchased	·	·	·	·	·	·	·	·	·	·	·	$2.0K
Net Stock Activity	·	·	·	·	$41M	·	·	·	·	·	·	$-2.0K
Financing Cash Flow	$-274M	$-187M	$70M	$54M	$52M	$224M	$89M	$105M	$207M	$226M	·	·
Net Change in Cash	$-37M	$23M	$39M	$-354M	$-124M	$364M	$105M	$-55M	$2M	$-33M	$8M	$111M
Taxes Paid	$36.0K	$-114.0K	$-118.0K	$40.0K	$1M	·	$2M	$0	$0	·	·	·
Free Cash Flow	·	·	$-175M	$-243M	$-39M	$147M	$27M	$-160M	$-205M	$-259M	$-114M	$-27M
Levered FCF	·	·	$-216M	$-276M	$-62M	$126M	$9M	·	·	·	·	·

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	-429.5%	-41.8%	-79.0%	-121.7%	-80.8%	32.9%	·	·	-14918.8%	-61.0%	-729.2%	-207.9%
Net Margin	398.4%	10.7%	-92.5%	-138.2%	-87.9%	27.8%	·	·	-15306.6%	-67.0%	-743.2%	-280.1%
Pretax Margin	-434.2%	10.7%	-92.6%	-138.2%	-87.9%	28.5%	·	·	·	·	·	·
EBITDA Margin	-426.4%	-41.1%	-77.8%	-121.7%	-80.8%	32.9%	·	·	-14918.8%	-61.0%	-729.2%	-205.8%
ROA	47.5%	5.3%	-42.9%	-50.3%	-37.8%	21.1%	35.3%	-159.8%	-139.7%	-65.2%	-111.7%	-74.3%
ROE	185.8%	-25.9%	145.5%	248.8%	-251.3%	49.3%	177.5%	1598.2%	-930.7%	-1778.5%	-736.9%	575.6%
ROIC	-296.9%	·	104.9%	186.9%	-270.0%	54.2%	99.2%	·	·	·	·	·

Liquidità e Solvibilità 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.5	1.2	1.4	2.7	3.6	5.3	3.0	2.5	5.1	2.9	1.9	3.5
Quick Ratio	1.4	0.8	1.1	2.2	3.3	4.8	2.8	2.2	4.5	2.2	1.5	3.0
Interest Coverage	-20.1	-4.1	-5.0	-7.9	-11.5	7.4	6.1	-21.1	-24.3	-14.5	-6638.4	-16.6

Efficienza 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.1	0.5	0.5	0.4	0.4	0.8	·	0.0	0.0	1.0	0.2	0.3
Inventory Turnover	3.7	1.8	3.1	1.8	1.4	1.4	·	·	·	·	·	·
Receivables Turnover	0.7	1.4	1.4	1.8	2.3	3.2	·	·	·	111.2	15.1	23.1

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$0.50	$-1.14	$-1.72	$-1.74	$1.27	$3.87	$1.50	$-0.56	$0.53	$0.53	$-0.19	$2.01
Revenue / Share	$0.36	$2.32	$2.73	$2.72	$4.33	$5.70	·	·	·	·	·	·
Cash Flow / Share	$-1.18	$-0.18	$-1.86	$-3.11	$-0.50	$1.85	$0.39	·	·	·	·	·
Cash / Share	$0.73	$1.09	$0.92	$0.81	$5.42	$7.46	$2.52	$1.06	$2.12	$3.20	$4.76	$4.52
EPS (TTM)	$1.43	$0.25	$-2.53	$-3.76	$-3.81	$1.62	$1.23	$-3.22	$-4.48	$-3.43	·	·

Tassi di Crescita 7

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	59.8%	-89.7%	21.9%	-35.4%	-31.4%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-41.5%	-56.8%	-18.5%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-38.4%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	472.0%	·	·	·	·	·	·	·	·	·	·	·
EPS CAGR 5Y	-2.5%	·	·	·	·	·	·	·	·	·	·	·
Net Income YoY	489.4%	·	·	·	·	·	·	·	·	·	·	·
Net Income CAGR 5Y	4.9%	·	·	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$42M	$26M	$257M	$211M	$327M	$476M	$356M	$0	$2M	$190M	$30M	$31M
Net Income TTM	$168M	$29M	$-238M	$-292M	$-287M	$132M	$90M	$-209M	$-238M	$-127M	$-223M	$-87M
Market Cap	$172M	$160M	$374M	$625M	$1.23B	$1.26B	$1.27B	$618M	$527M	$1.10B	$764M	$543M
P/E	1.0	5.5	-1.3	-2.1	-4.2	10.7	14.6	-2.8	-2.0	-8.2	·	·
P/S	4.1	6.0	1.5	3.0	3.8	2.6	3.6	·	338.4	5.8	25.4	17.4
P/B	2.8	-1.2	-1.9	-4.5	12.6	4.5	12.0	-16.0	16.5	53.5	-123.0	8.1
P / Tangible Book	4.2	·	·	·	13.2	4.5	·	·	·	·	·	·
P / Cash Flow	-1.2	-7.8	-2.1	-2.6	-32.8	8.2	44.7	-3.9	-2.6	-4.3	-7.1	-22.7
P / FCF	·	·	-2.1	-2.6	-31.7	8.6	47.8	-3.9	-2.6	-4.2	-6.7	-20.3
Earnings Yield	100.7%	18.1%	-76.0%	-47.5%	-23.9%	9.3%	6.8%	-35.6%	-50.9%	-12.2%	·	·

Conto Economico 16

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$14M	$12M	$13M	$12M	$10M	$8M	$8M	$6M	$10M	$2M	$92M	$75M	$59M	$32M	$45M	$45M
Cost of Revenue	$4M	$4M	$4M	$4M	$3M	$3M	$3M	$3M	$2M	$1M	$85M	$33M	$25M	$17M	$14M	$35M
R&D Expense	$21M	$22M	$31M	$27M	$26M	$24M	$21M	$22M	$21M	$28M	$26M	$26M	$23M	$34M	$29M	$46M
SG&A Expense	$21M	$23M	$24M	$25M	$26M	$26M	$30M	$28M	$28M	$40M	$49M	$48M	$45M	$49M	$54M	$45M
Operating Expenses	$47M	$48M	$59M	$56M	$56M	$53M	$53M	$53M	$50M	$70M	$160M	$107M	$93M	$100M	$97M	$126M
Operating Income	$-32M	$-36M	$-46M	$-44M	$-45M	$-45M	$-45M	$-47M	$-40M	$-68M	$-69M	$-32M	$-35M	$-68M	$-51M	$-80M
Interest Expense	$2M	$2M	$2M	$2M	$2M	$2M	$727.0K	$3M	$4M	$3M	$11M	$10M	$10M	$10M	$9M	$8M
Other Non-op	$1M	$1M	$2M	$2M	$3M	$187.0K	$1M	$2M	$1M	$3M	$-129.0K	$2M	$2M	$2M	$2M	$1M
Pretax Income	$-33M	$-37M	$-46M	$-45M	$-45M	$-47M	$-45M	$-48M	$-55M	$-68M	$-80M	$-40M	$-43M	$-76M	$-59M	$-87M
Income Tax	·	·	·	·	·	·	·	·	·	·	$0	$-380.0K	·	·	·	·
Net Income	$-21M	$-38M	$-38M	$-36M	$298M	$-57M	$-51M	$-11M	$-13M	$103M	$-80M	$-40M	$-43M	$-76M	$-59M	$-87M
EPS (Basic)	$-0.13	$-0.28	$-0.34	$-0.31	$2.57	$-0.49	$-0.46	$-0.09	$-0.11	$0.91	$-0.67	$-0.41	$-0.49	$-0.96	$-0.76	$-1.11
EPS (Diluted)	$-0.13	$-0.28	$-0.34	$-0.31	$2.57	$2.57	$-0.46	$-0.09	$-0.11	$0.91	$-0.67	$-0.41	$-0.49	$-0.96	$-0.76	$-1.11
Shares (Basic)	154,816,912	136,398,303	·	116,229,170	116,077,710	115,857,780	·	115,210,091	114,819,965	112,749,306	·	97,738,509	87,269,614	79,268,853	·	77,746,895
Shares (Diluted)	154,816,912	136,398,303	·	116,229,170	116,077,710	116,077,710	·	115,210,091	114,819,965	112,749,306	·	97,738,509	87,269,614	79,268,853	·	77,746,895
EBITDA	$-32M	$-36M	·	$-44M	$-45M	$-45M	·	$-6M	$-20M	$-42M	·	$-31M	$-34M	$-68M	·	$-80M

Stato Patrimoniale 26

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$83M	$115M	$89M	$103M	$217M	$82M	$126M	$98M	$159M	$260M	$103M	$80M	$73M	$16M	$64M	$287M
Short-term Investments	$22M	$52M	$83M	$88M	$21M	·	·	·	·	·	$15M	$51M	$72M	$112M	·	·
Receivables	$14M	$22M	$18M	$9M	$5M	$60M	$111M	$168M	$175M	$252M	$261M	$217M	$141M	$101M	·	$91M
Inventory	$6M	$5M	$3M	$2M	$5M	$4M	$4M	$48M	$62M	$62M	$63M	$67M	$64M	$49M	·	$28M
Prepaid Expense	$5M	$9M	$6M	$9M	$12M	$16M	$10M	$14M	$14M	$14M	$11M	$16M	$18M	$21M	·	$22M
Current Assets	$134M	$206M	$207M	$461M	$380M	$310M	$342M	$369M	$558M	$627M	$476M	$444M	$385M	$316M	·	$448M
PP&E (Net)	·	·	$1M	$2M	$2M	$2M	$3M	$3M	$3M	$4M	$5M	$6M	$7M	$8M	·	$10M
Accum. Depreciation	·	·	·	·	·	·	·	·	·	·	·	·	·	$900.0K	·	·
Goodwill	·	·	·	·	·	·	·	·	·	·	$943.0K	$943.0K	·	·	·	·
Intangibles	$19M	$19M	$20M	$21M	$23M	$24M	$25M	$25M	$27M	$28M	$42M	$17M	·	·	·	·
Other Non-current Assets	$3M	$4M	$4M	$4M	$5M	$6M	$6M	$7M	$8M	$9M	$10M	$8M	$8M	$8M	·	$10M
Total Assets	$191M	$266M	$258M	$517M	$439M	$371M	$449M	$505M	$675M	$764M	$630M	$584M	$470M	$402M	·	$551M
Accounts Payable	$13M	$11M	$10M	$25M	$38M	$41M	$28M	$22M	$77M	$38M	$35M	$37M	$29M	$23M	·	$10M
Accrued Liabilities	$15M	$15M	$20M	$13M	$14M	$46M	$60M	$61M	$61M	$116M	$105M	$67M	$42M	$32M	·	$86M
Current Liabilities	$76M	$132M	$140M	$372M	$264M	$255M	$283M	$296M	$463M	$538M	$332M	$240M	$169M	$123M	·	$171M
Capital Leases	$459.0K	·	$1M	·	·	·	$3M	·	·	·	$5M	·	·	·	·	·
Deferred Tax	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	·	·	·	·
Other Non-current Liabilities	$18M	$17M	$18M	$18M	$17M	$31M	$29M	$29M	$28M	$3M	$13M	$4M	$102.0K	$102.0K	·	$102.0K
Total Liabilities	$130M	$187M	$197M	$429M	$320M	$555M	$581M	$593M	$759M	$845M	$823M	$717M	$644M	$599M	·	$648M
Common Stock	$15.0K	$15.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K	$11.0K	$11.0K	$11.0K	$9.0K	$8.0K	·	$7.0K
Paid-in Capital	$1.50B	$1.50B	$1.44B	$1.43B	$1.43B	$1.42B	$1.42B	$1.41B	$1.41B	$1.40B	$1.39B	$1.37B	$1.29B	$1.22B	·	$1.19B
Retained Earnings	$-1.44B	$-1.42B	$-1.38B	$-1.35B	$-1.31B	$-1.61B	$-1.55B	$-1.50B	$-1.49B	$-1.48B	$-1.58B	$-1.50B	$-1.46B	$-1.42B	·	$-1.28B
AOCI	$-281.0K	$-268.0K	$-195.0K	$-203.0K	$-275.0K	$-275.0K	$-275.0K	$-275.0K	$-272.0K	$-272.0K	$-248.0K	$-265.0K	$-297.0K	$-278.0K	·	$-270.0K
Stockholders' Equity	$61M	$79M	$61M	$88M	$120M	$-183M	$-132M	$-88M	$-84M	$-82M	$-193M	$-134M	$-175M	$-197M	$-137M	$-97M
Liabilities + Equity	$191M	$266M	$258M	$517M	$439M	$371M	$449M	$505M	$675M	$764M	$630M	$584M	$470M	$402M	·	$551M
Shares Outstanding	154,470,363	154,217,609	121,154,925	116,236,018	116,222,726	115,907,216	115,614,548	115,213,407	115,198,655	113,496,854	112,215,260	109,113,046	94,442,014	80,488,296	78,851,516	77,770,593

Flusso di cassa 12

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$862.0K	$881.0K	$300.0K	$300.0K	$300.0K	$400.0K	$100.0K	$400.0K	$500.0K	$600.0K	$700.0K	$800.0K	$800.0K	$900.0K	$1M	$900.0K
Stock-based Comp	$3M	$2M	$3M	$3M	$5M	$5M	$6M	$7M	$7M	$7M	$11M	$10M	$10M	$12M	$12M	$12M
Amort. of Intangibles	$600.0K	$600.0K	$600.0K	$700.0K	$600.0K	$700.0K	$700.0K	$1M	$700.0K	$900.0K	·	·	·	·	·	·
Other Non-cash	·	·	·	·	·	$25M	·	·	·	$-158M	·	·	·	·	·	·
Operating Cash Flow	$-62M	$-58M	$-20M	$-46M	$-47M	$-26M	$29M	$-62M	$60M	$-47M	$-13M	$-54M	$-39M	$-69M	$-100M	$-37M
CapEx	·	·	·	·	·	·	·	·	·	·	·	$0	$100.0K	$152.0K	·	$457.0K
Investing Cash Flow	$30M	$31M	$-3M	$-67M	$463M	$-17M	$-542.0K	$444.0K	$28M	$203M	$35M	$51M	$41M	$18M	$-130M	$-457.0K
Stock Issued	$0	$54M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Net Stock Activity	·	$54M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$144.0K	$54M	$8M	$2.0K	$-282M	$-264.0K	$231.0K	$-167.0K	$-188M	$887.0K	$366.0K	$11M	$54M	$4M	$7M	$49M
Net Change in Cash	$-32M	$26M	$-14M	$-114M	$134M	$-44M	$28M	$-62M	$-101M	$157M	$23M	$7M	$57M	$-47M	$-223M	$11M
Free Cash Flow	·	·	·	·	·	·	·	·	·	·	·	·	·	$-69M	·	·

Redditività 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-226.0%	-293.7%	·	-383.1%	-443.6%	-597.9%	·	-9.0%	-31.6%	-55.2%	·	-42.9%	-58.8%	-208.9%	·	-177.1%
Net Margin	-144.2%	-311.4%	·	-307.1%	2903.9%	-744.4%	·	-15.2%	-19.9%	133.5%	·	-53.2%	-73.0%	-233.5%	·	-190.8%
Pretax Margin	-233.1%	-300.0%	·	-384.7%	-437.5%	-623.7%	·	-15.2%	-19.9%	133.5%	·	-53.7%	-73.0%	-233.5%	·	-190.8%
EBITDA Margin	-226.0%	-293.7%	·	-380.6%	-440.7%	-592.6%	·	-8.5%	-30.8%	-54.4%	·	-41.9%	-57.5%	-208.9%	·	-177.1%
ROA	-6.5%	-12.0%	·	-7.0%	53.4%	-10.0%	·	-2.0%	-2.3%	17.6%	·	-7.0%	-8.4%	-15.2%	·	-13.4%
ROE	-22.8%	73.1%	·	35709.6%	1667.3%	42.6%	·	9.7%	10.0%	-73.9%	·	34.4%	43.4%	82.3%	·	-515.4%
ROIC	·	·	·	·	·	·	·	·	·	·	·	23.7%	·	·	·	·

Liquidità e Solvibilità 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	1.8	1.6	·	1.2	1.4	1.2	·	1.2	1.2	1.2	·	1.9	2.3	2.6	·	2.6
Quick Ratio	1.6	1.4	·	0.5	0.9	0.6	·	0.9	0.7	1.0	·	1.5	1.7	1.9	·	2.2
Interest Coverage	-13.9	-16.5	·	-19.1	-20.0	-21.1	·	-1.2	-3.8	-3.8	·	-3.1	-3.5	-7.0	·	-10.7

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.0	0.0	·	0.0	0.0	0.0	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	0.8	0.9	·	0.1	0.1	0.1	·	0.4	0.4	0.6	·	0.7	0.5	0.4	·	1.1
Receivables Turnover	1.5	0.3	·	0.1	0.1	0.0	·	0.4	0.4	0.4	·	0.5	0.5	0.3	·	0.4

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.39	$0.51	·	$0.76	$1.03	$-1.58	·	$-0.76	$-0.73	$-0.72	·	$-1.22	$-1.85	$-2.44	·	$-1.25
Revenue / Share	$0.09	$0.09	·	$0.10	$0.09	$0.07	·	$0.61	$0.57	$0.61	·	$0.76	$0.67	$0.41	·	$0.58
Cash Flow / Share	·	$-0.42	·	·	·	$-0.22	·	·	·	$-0.37	·	·	·	$-0.87	·	·
Cash / Share	$0.54	$0.75	·	$0.89	$1.87	$0.71	·	$0.85	$1.38	$2.29	·	$0.74	$0.77	$0.20	·	$3.69
EPS (TTM)	$-1.06	$1.64	·	$4.37	$4.59	$1.91	·	$0.04	$-0.28	$-0.66	·	$-2.62	$-3.32	$-3.48	·	$-3.55

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$51M	$47M	·	$37M	$32M	$32M	·	$110M	$179M	$227M	·	$211M	$182M	$183M	·	$239M
Net Income TTM	$-132M	$186M	·	$155M	$180M	$-131M	·	$-450.0K	$-29M	$-59M	·	$-217M	$-264M	$-271M	·	$-279M
Market Cap	$216M	$261M	·	$191M	$85M	$94M	·	$120M	$199M	$271M	·	$408M	$403M	$551M	·	$747M
P/E	-1.3	1.0	·	0.4	0.2	0.4	·	26.0	-6.2	-3.6	·	-1.4	-1.3	-2.0	·	-2.7
P/S	4.2	5.6	·	5.1	2.7	3.0	·	1.1	1.1	1.2	·	1.9	2.2	3.0	·	3.1
P/B	3.6	3.3	·	2.2	0.7	-0.5	·	-1.4	-2.4	-3.3	·	-3.1	-2.3	-2.8	·	-7.7
P / Tangible Book	5.1	4.4	·	2.8	0.9	·	·	·	·	·	·	·	·	·	·	·
P / Cash Flow	·	-4.5	·	·	·	-3.6	·	·	·	-5.8	·	·	·	-8.0	·	·
Earnings Yield	-75.7%	97.0%	·	266.5%	627.9%	236.7%	·	3.9%	-16.2%	-27.6%	·	-70.0%	-77.8%	-50.9%	·	-36.9%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$42M	$26M	$257M	$211M	$327M
Margine Operativo %	-429.5%	-41.8%	-79.0%	-121.7%	-80.8%
Utile netto	$168M	$29M	$-238M	$-292M	$-287M
EPS Diluito	$1.43	$0.25	$-2.53	$-3.76	$-3.81

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	1.5	1.2	1.4	2.7	3.6
Quick Ratio	1.4	0.8	1.1	2.2	3.3

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	·	·	$-175M	$-243M	$-39M

Proprietari istituzionali (13F) 161 filer · $91.7M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 161

Valore detenuto $91.7M

Nuove posizioni 12

Posizioni chiuse 19

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
12 (-32 vs trimestre precedente)	19 (+12 vs trimestre precedente)	61 (+14 vs trimestre precedente)	45 (+8 vs trimestre precedente)	-1.8M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
BlackRock, Inc.	$16.804.642	12.003.316	18,34%	Azioni
VANGUARD GROUP INC	$14.241.029	10.028.893	15,54%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$8.329.286	5.949.490	9,09%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$5.161.010	3.685.567	5,63%	Azioni
SAMSARA BIOCAPITAL, LLC	$4.799.999	3.428.571	5,24%	Azioni
Kohlberg Kravis Roberts & Co. L.P.	$4.184.019	3.036.076	4,57%	Azioni
STATE STREET CORP	$3.335.227	2.382.305	3,64%	Azioni
TWO SIGMA INVESTMENTS, LP	$3.163.177	2.259.412	3,45%	Azioni
CM Management, LLC	$2.940.000	2.100.000	3,21%	Azioni
Alyeska Investment Group, L.P.	$2.426.528	1.733.234	2,65%	Azioni
Hudson Bay Capital Management LP	$2.370.200	1.693.000	2,59%	Azioni
AQR CAPITAL MANAGEMENT LLC	$1.862.281	1.330.201	2,03%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.719.297	1.228.069	1,88%	Azioni
PANAGORA ASSET MANAGEMENT INC	$1.592.255	1.137.325	1,74%	Azioni
NORTHERN TRUST CORP	$1.581.259	1.129.470	1,73%	Azioni
VANGUARD FIDUCIARY TRUST CO	$1.422.387	1.015.991	1,55%	Azioni
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$1.260.000	899.999	1,37%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$1.236.836	883.454	1,35%	Azioni
UBS Group AG	$1.064.501	760.358	1,16%	Azioni
GOLDMAN SACHS GROUP INC	$842.905	602.075	0,92%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$788.278	563.056	0,86%	Azioni
STRS OHIO	$553.840	395.600	0,60%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$547.400	391.000	0,60%	Azioni
Invesco Ltd.	$495.491	353.922	0,54%	Azioni
Bank of New York Mellon Corp	$447.563	319.687	0,49%	Azioni
TWO SIGMA ADVISERS, LP	$436.792	307.600	0,48%	Azioni
BANK OF AMERICA CORP /DE/	$423.540	302.528	0,46%	Azioni
ALLIANCEBERNSTEIN L.P.	$375.011	221.900	0,41%	Azioni
Jefferies Financial Group Inc.	$352.800	252.000	0,38%	Azioni
Nuveen, LLC	$351.049	250.749	0,38%	Azioni
MORGAN STANLEY	$323.048	230.748	0,35%	Azioni
Tyche Wealth Partners LLC	$281.683	201.202	0,31%	Azioni
BARCLAYS PLC	$281.601	201.143	0,31%	Azioni
IEQ CAPITAL, LLC	$227.294	162.353	0,25%	Azioni
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	$223.986	159.990	0,24%	Azioni
RHUMBLINE ADVISERS	$199.296	142.361	0,22%	Azioni
ENVESTNET ASSET MANAGEMENT INC	$197.218	140.870	0,22%	Azioni
PVG ASSET MANAGEMENT CORP	$186.529	133.235	0,20%	Azioni
DEUTSCHE BANK AG\	$178.669	127.621	0,19%	Azioni
XTX Topco Ltd	$172.896	123.497	0,19%	Azioni
CITADEL ADVISORS LLC	$162.120	115.800	0,18%	Opzione Put
Summit Financial, LLC	$160.805	114.861	0,18%	Azioni
WELLS FARGO & COMPANY/MN	$158.064	112.903	0,17%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$153.478	109.627	0,17%	Azioni
Shay Capital LLC	$147.456	105.326	0,16%	Azioni
Corient Private Wealth LP	$140.000	100.000	0,15%	Azioni
HSBC HOLDINGS PLC	$130.950	91.895	0,14%	Azioni
CWM, LLC	$118.876	70.341	0,13%	Azioni
MetLife Investment Management, LLC	$110.058	78.613	0,12%	Azioni
SEI INVESTMENTS CO	$107.281	76.629	0,12%	Azioni

Mostra tutti i 161 proprietari istituzionali →

Attivisti e proprietari del 5%+ 2 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
KKR BIOSIMILAR L.P., KKR BIOSIMILAR GP LLC, KKR FUND HOLDINGS L.P., KKR FUND HOLDINGS GP LIMITED, KKR GROUP HOLDINGS CORP., KKR & CO. INC., KKR MANAGEMENT LLC, HENRY R. KRAVIS, GEORGE R. ROBERTS ×3 depositi	02 Dicembre 2019	·	Deposito iniziale	·	SEC
Sofinnova Venture Partners VII, L.P. (“SVP VII”), Sofinnova Management VII, L.L.C. (“SM VII”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Eric P. Buatois (“Buatois”) ×4 depositi	14 Febbraio 2018	·	Deposito iniziale	Investimento passivo	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 29 insider · 10 dirigenti · 18 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Netto 12m
Dennis M Lanfear	President & CEO	29 Maggio 2026 A	1.048.235	$0
Bryan J Mcmichael	Chief Financial Officer	29 Maggio 2026 A	133.736	$0
Mcdavid Stilwell	Chief Financial Officer	31 Dicembre 2023 F	75.305	$0
Jean-Frederic Viret	Chief Financial Officer	01 Febbraio 2021 M	61.295	$0
Vincent R Anicetti	Chief Operating Officer	06 Luglio 2021 A	124.790	$0
Paul Reider	Chief Commercial Officer	20 Gennaio 2025 F	82.069	$0
Vladimir Vexler	Chief Scientific Officer	31 Marzo 2023 F	116.361	$0
Barbara K Finck	Chief Medical Officer	10 Settembre 2018 M	37.043	$0
Peter K. Watler	Chief Technical Officer	01 Febbraio 2018 A	5.900	$0
Alan C. Herman	Chief Scientific Officer	15 Dicembre 2017 A	50.460	$0
Michael Lee Ryan	Direttore	05 Giugno 2026 A	30.000	$0
Jill O'Donnell-Tormey	Direttore	05 Giugno 2026 A	30.000	$0
Charles W. Newton	Direttore	05 Giugno 2026 A	30.000	$0
Lee Nisley Newcomer	Direttore	05 Giugno 2026 A	30.000	$0
Ali J. Satvat	Direttore	05 Giugno 2026 A	30.000	$0
Rita A Karachun	Direttore	05 Giugno 2026 A	30.000	$0
Mats Wahlstrom	Direttore	05 Giugno 2026 A	30.000	$0
Georgia Erbez	Direttore	12 Giugno 2025 A	·	$0
Kimberly Jo Tzoumakas	Direttore	03 Giugno 2024 A	·	$0
Mark Stolper	Direttore	03 Giugno 2024 A	·	$0
Dr. James I. Healy	Direttore	07 Gennaio 2022 A	0	$0
MENDELSON ALAN C	Direttore	21 Maggio 2021 A	·	$0
Mary T Szela	Direttore	11 Gennaio 2021 A	0	$0
Bryan V Lawlis	Direttore	11 Gennaio 2021 A	·	$0
Samuel R Nussbaum MD	Direttore	11 Gennaio 2021 A	·	$0
Christos Richards	Direttore	10 Gennaio 2020 A	63.836	$0
August J. Troendle	Direttore	01 Febbraio 2018 A	29.994	$0
FMR LLC	·	08 Agosto 2016 S	361.594	$0
Daiichi Sankyo Company, LTD	·	12 Novembre 2014 C	2.867.426	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 16 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
QQQS · Invesco Exchange-Traded Fund Trust …	0,46%	88.872 SH	01 Ottobre 2026	Giornaliero
IWC · iShares Trust	0,04%	445.148 SH	11 Settembre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,01%	10.938 SH	01 Ottobre 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	750.573 SH	19 Agosto 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,01%	76.202 SH	19 Agosto 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,01%	210.687 SH	01 Ottobre 2026	Giornaliero
RSSL · Global X Funds	0,01%	62.442 NS	31 Luglio 2026	N-PORT
IWM · iShares Trust	0,01%	3.158.896 SH	11 Settembre 2026	Giornaliero
IWO · iShares Trust	0,00%	436.778 SH	11 Settembre 2026	Giornaliero
IWV · iShares Trust	0,00%	17.030 SH	03 Settembre 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,00%	15.055 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	1.863.589 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	3.953.617 SH	19 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,00%	49.507 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	7.172 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	737.019 SH	11 Settembre 2026	Giornaliero

CHRS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 12 analisti COMPRA

Target mediano $8.50 +632,8%

4 33,3% Acquisto forte

6 50,0% Compra

2 16,7% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

4 analisti · 2026-10-03

Target medio $7.75 +568,1%

← Sotto tutti i target Prezzo attuale $1.16

Basso$4.00 Media$7.75 Alto$10.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
CHRS	$172M	1.0	59.8%	398.4%	185.8%	·
WHWK	$114M	-7.3	-72.5%	-288.3%	-13.4%	·
TRDA	$394M	-3.0	-87.9%	-565.5%	-41.9%	·
ELDN	$114M	-2.9	·	·	-69.4%	·
PYXS	$72M	-0.9	-14.2%	-574.5%	-112.9%	·
CUE	$29M	-1.1	195.8%	-96.9%	-119.3%	·
NKTX	$131M	-1.3	·	·	-31.1%	·
CNTN	$112M	-2.7	·	·	-18.0%	·
ORGO	$658M	34.5	17.0%	6.6%	13.9%	·
DTIL	$100M	-1.2	-50.1%	-133.4%	-72.4%	·
ALXO	$61M	-0.6	·	·	-225.0%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

CHRS Coherus Oncology, Inc. - Common Stock